May 11, 2023
min read

Triall invited to speak at DIA 2023 in Boston

Triall CEO Hadil has been invited to host two presentations at DIA 2023, the world’s premier biopharma industry event.

We’re thrilled to share that our CEO Hadil Es-Sbai has been invited to host two presentations at the DIA 2023 Global Annual Meeting, the world’s premier biopharma industry event.

DIA 2023 is a 5-day event that attracts over 5,000 industry professionals, regulators, academics, and patient representatives from across the globe to network, problem-solve, and discuss key challenges facing the Life Sciences community.

As part of the Data & Technology track, Triall will be hosting an educational presentation and workshop, covering the real-world applications of decentralised and privacy-enhancing technologies in the clinical research domain. The event therefore offers a unique opportunity for us to present and validate our solutions and tech stack with a global audience of experts.

Triall presentations:

📅 Monday (June 26) 12:00pm - #115: Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality

📅 Monday (June 26) 16:15pm - #153: The True Decentralisation of Clinical Trials: Benefits and Drawbacks of Blockchain Technology

We look forward to contributing to this event and hope to see you there!

Check out the full program.

Want to receive our latest insights directly in your inbox?

The Triall Newsletter provides a concise overview of product innovation updates, upcoming events, and anything else Triall-related.